Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ixobran 10 vs Xarelto (rivaroxaban 10 mg) in healthy Thai volunteers under fasting
TCTR20220908003Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20220908003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220908003.